These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35292609)

  • 1. Therapeutic Drug Monitoring of Antibiotics in Critically Ill Children: An Observational Study in a Pediatric Intensive Care Unit.
    de Cacqueray N; Boujaafar S; Bille E; Moulin F; Gana I; Benaboud S; Hirt D; Béranger A; Toubiana J; Renolleau S; Tréluyer JM; Oualha M
    Ther Drug Monit; 2022 Apr; 44(2):319-327. PubMed ID: 35292609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients.
    Schoenenberger-Arnaiz JA; Ahmad-Diaz F; Miralbes-Torner M; Aragones-Eroles A; Cano-Marron M; Palomar-Martinez M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e30-e35. PubMed ID: 32296502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience.
    Richter DC; Frey O; Röhr A; Roberts JA; Köberer A; Fuchs T; Papadimas N; Heinzel-Gutenbrunner M; Brenner T; Lichtenstern C; Weigand MA; Brinkmann A
    Infection; 2019 Dec; 47(6):1001-1011. PubMed ID: 31473974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.
    Abdulla A; Ewoldt TMJ; Hunfeld NGM; Muller AE; Rietdijk WJR; Polinder S; van Gelder T; Endeman H; Koch BCP
    BMC Infect Dis; 2020 Jan; 20(1):57. PubMed ID: 31952493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper
    Abdul-Aziz MH; Alffenaar JC; Bassetti M; Bracht H; Dimopoulos G; Marriott D; Neely MN; Paiva JA; Pea F; Sjovall F; Timsit JF; Udy AA; Wicha SG; Zeitlinger M; De Waele JJ; Roberts JA; ; ; ;
    Intensive Care Med; 2020 Jun; 46(6):1127-1153. PubMed ID: 32383061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept.
    Roberts JA; Ulldemolins M; Roberts MS; McWhinney B; Ungerer J; Paterson DL; Lipman J
    Int J Antimicrob Agents; 2010 Oct; 36(4):332-9. PubMed ID: 20685085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Drug Monitoring of Antibiotics in Critically Ill Patients: Current Practice and Future Perspectives With a Focus on Clinical Outcome.
    Koch BCP; Muller AE; Hunfeld NGM; de Winter BCM; Ewoldt TMJ; Abdulla A; Endeman H
    Ther Drug Monit; 2022 Feb; 44(1):11-18. PubMed ID: 34772892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol for ADAPT-TDM: A beta-lactam antibiotic Dose AdaPtation feasibility randomised controlled Trial using Therapeutic Drug Monitoring.
    Pai Mangalore R; Chai MG; Pope J; Lee SJ; Padiglione A; Diehl A; Roberts L; Sim K; Rawson-Harris P; Wicha S; Schneider HG; Peel TN; Jenney A; Ayton D; Peleg AY; Udy AA
    BMJ Open; 2024 Jul; 14(6):e083635. PubMed ID: 38951004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial therapeutic drug monitoring in critically ill adult patients - An international perspective on access, utilisation, and barriers.
    Williams P; Cotta MO; Tabah A; Sandaradura I; Kanji S; Scheetz MH; Imani S; Elhadi M; Pardos SL; Schellack N; Sanches C; Timsit JF; Xie J; Farkas A; Wilks K; Roberts JA; ;
    Int J Antimicrob Agents; 2024 Aug; 64(2):107192. PubMed ID: 38734215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic therapy in sepsis: No next time for a second chance!
    Shahrami B; Sharif M; Sefidani Forough A; Najmeddin F; Arabzadeh AA; Mojtahedzadeh M
    J Clin Pharm Ther; 2021 Aug; 46(4):872-876. PubMed ID: 33710622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ONTAI study - a survey on antimicrobial dosing and the practice of therapeutic drug monitoring in German intensive care units.
    Liebchen U; Paal M; Scharf C; Schroeder I; Grabein B; Zander J; Siebers C; Zoller M
    J Crit Care; 2020 Dec; 60():260-266. PubMed ID: 32932111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of meropenem and pharmacokinetic-pharmacodynamic target assessment in critically ill pediatric patients from a prospective observational study.
    Maimongkol P; Yonwises W; Anugulruengkitt S; Sophonphan J; Treyaprasert W; Wacharachaisurapol N
    Int J Infect Dis; 2022 Jul; 120():96-102. PubMed ID: 35489632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a β-lactam therapeutic drug monitoring program: Experience from a large academic medical center.
    Venugopalan V; Hamza M; Santevecchi B; DeSear K; Cherabuddi K; Peloquin CA; Alshaer MH
    Am J Health Syst Pharm; 2022 Sep; 79(18):1586-1591. PubMed ID: 35704702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT).
    Abdulla A; Dijkstra A; Hunfeld NGM; Endeman H; Bahmany S; Ewoldt TMJ; Muller AE; van Gelder T; Gommers D; Koch BCP
    Crit Care; 2020 Sep; 24(1):558. PubMed ID: 32933574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Lactam Therapeutic Drug Monitoring in Critically Ill Patients: Weighing the Challenges and Opportunities to Assess Clinical Value.
    Dilworth TJ; Schulz LT; Micek ST; Kollef MH; Rose WE
    Crit Care Explor; 2022 Jul; 4(7):e0726. PubMed ID: 35815181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Drug Monitoring of Antibiotic Drugs in Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis: A Critical Review.
    Matusik E; Boidin C; Friggeri A; Richard JC; Bitker L; Roberts JA; Goutelle S
    Ther Drug Monit; 2022 Feb; 44(1):86-102. PubMed ID: 34772891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients.
    Gatti M; Cojutti PG; Bartoletti M; Tonetti T; Bianchini A; Ramirez S; Pizzilli G; Ambretti S; Giannella M; Mancini R; Siniscalchi A; Viale P; Pea F
    Crit Care; 2022 Jun; 26(1):178. PubMed ID: 35701812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring of β-lactam antibiotics in the ICU.
    Dhaese S; Van Vooren S; Boelens J; De Waele J
    Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1155-1164. PubMed ID: 32597263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d'Anesthésie et Réanimation-SFAR).
    Guilhaumou R; Benaboud S; Bennis Y; Dahyot-Fizelier C; Dailly E; Gandia P; Goutelle S; Lefeuvre S; Mongardon N; Roger C; Scala-Bertola J; Lemaitre F; Garnier M
    Crit Care; 2019 Mar; 23(1):104. PubMed ID: 30925922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.